• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西米纳斯吉拉斯州贝洛奥里藏特市,2012 年 10 月 18-19 日,第五届国际血栓形成与抗凝研讨会(ISTA V)亮点。

Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.

机构信息

Duke Clinical Research Institute, Duke University Medical Center, P.O. Box 3850, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC 27705, USA.

出版信息

J Thromb Thrombolysis. 2013 Jul;36(1):115-30. doi: 10.1007/s11239-013-0906-z.

DOI:10.1007/s11239-013-0906-z
PMID:23494487
Abstract

To discuss and share knowledge about advances in the care of patients with thrombotic disorders, the Fifth International Symposium of Thrombosis and Anticoagulation was held in Belo Horizonte, Minas Gerais, Brazil, on October 18-19, 2012. This scientific program was developed by clinicians for clinicians and was promoted by three major clinical research institutes: the Brazilian Clinical Research Institute, the Duke Clinical Research Institute of the Duke University School of Medicine, and Hospital do Coração Research Institute. Comprising 2 days of academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists. This paper summarizes the symposium proceedings.

摘要

为了讨论和分享血栓性疾病患者护理方面的进展,第五届国际血栓形成与抗凝研讨会于 2012 年 10 月 18 日至 19 日在巴西米纳斯吉拉斯州贝洛奥里藏特举行。本次科学计划由临床医生为临床医生制定,并由三个主要临床研究机构:巴西临床研究协会、杜克大学医学部杜克临床研究协会和心脏医院研究协会共同推广。该研讨会为期两天,包括学术报告和公开讨论,主要目标是通过召集国内外有远见、有思想领导力和专注的临床科学家,教育、激励和鼓舞内科医生、心脏病专家、血液学家和其他医生。本文总结了研讨会的会议记录。

相似文献

1
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.巴西米纳斯吉拉斯州贝洛奥里藏特市,2012 年 10 月 18-19 日,第五届国际血栓形成与抗凝研讨会(ISTA V)亮点。
J Thromb Thrombolysis. 2013 Jul;36(1):115-30. doi: 10.1007/s11239-013-0906-z.
2
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.2011 年 10 月 20-21 日,巴西萨尔瓦多举行了第四届国际血栓形成与抗凝研讨会(ISTA),本文摘译了此次会议的部分内容。
J Thromb Thrombolysis. 2012 Jul;34(1):143-63. doi: 10.1007/s11239-012-0700-3.
3
Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil.第九届国际血栓形成与抗凝研讨会(ISTAIX)要点,2016 年 10 月 15 日,巴西萨尔瓦多,巴伊亚州。
J Thromb Thrombolysis. 2017 Nov;44(4):544-555. doi: 10.1007/s11239-017-1551-8.
4
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil.第三届国际血栓与抗凝研讨会(ISTA)要点,2010 年 10 月 14 日-16 日,巴西圣保罗。
J Thromb Thrombolysis. 2011 Aug;32(2):242-66. doi: 10.1007/s11239-011-0592-7.
5
Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil.第十届国际血栓形成与抗凝研讨会(ISTA X)亮点报道,2017 年 9 月 22 日至 23 日,巴西萨尔瓦多,巴伊亚州。
J Thromb Thrombolysis. 2018 May;45(4):578-587. doi: 10.1007/s11239-018-1639-9.
6
Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil.2008年10月23日至25日于巴西圣保罗举行的第一届内科血栓形成与抗凝国际研讨会亮点
J Thromb Thrombolysis. 2009 Jul;28(1):106-16. doi: 10.1007/s11239-009-0324-4. Epub 2009 Mar 26.
7
Covid-19 Impact on the Music Sector in Belo Horizonte (Minas Gerais, Brazil).新冠疫情对贝洛奥里藏特(巴西米纳斯吉拉斯州)音乐行业的影响。
Front Sociol. 2021 Jun 29;6:643344. doi: 10.3389/fsoc.2021.643344. eCollection 2021.
8
Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil.2009年10月22日至23日于巴西圣保罗举行的第二届国际血栓形成与抗凝研讨会(ISTA)亮点
J Thromb Thrombolysis. 2010 May;29(4):395-408. doi: 10.1007/s11239-010-0454-8.
9
[Out-of-pocket drug expenditures by retirees and pensioners 60 years and older in Belo Horizonte, Minas Gerais, Brazil].[巴西米纳斯吉拉斯州贝洛奥里藏特60岁及以上退休人员和领取养老金者的自付药品费用]
Cad Saude Publica. 2007 Jun;23(6):1423-30. doi: 10.1590/s0102-311x2007000600017.
10
A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries.在发达国家和发展中国家开展的实验性钩虫疫苗临床试验中知情同意质量的比较
PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005327. doi: 10.1371/journal.pntd.0005327. eCollection 2017 Jan.

本文引用的文献

1
Mechanical valve thrombosis with dabigatran.达比加群导致的机械瓣膜血栓形成
J Am Coll Cardiol. 2012 Oct 23;60(17):1710-1. doi: 10.1016/j.jacc.2012.06.039. Epub 2012 Sep 26.
2
Brain natriuretic peptide: a relevant marker to rule out delayed atrial fibrillation in stroke patient.脑利钠肽:排除脑卒中患者心房颤动的相关标志物。
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e103-10. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.010. Epub 2012 Sep 23.
3
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.
比较阿哌沙班与华法林在心房颤动患者肾功能方面的疗效:来自 ARISTOTLE 试验的见解。
Eur Heart J. 2012 Nov;33(22):2821-30. doi: 10.1093/eurheartj/ehs274. Epub 2012 Aug 29.
4
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial.Vorapaxar 用于预防既往心肌梗死患者的血栓事件复发:TRA 2°P-TIMI 50 试验的预先设定亚组分析。
Lancet. 2012 Oct 13;380(9850):1317-24. doi: 10.1016/S0140-6736(12)61269-0. Epub 2012 Aug 26.
5
Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.老年患者生物瓣主动脉瓣的早期抗凝治疗:来自胸外科医师学会成人心脏外科学国家数据库的结果。
J Am Coll Cardiol. 2012 Sep 11;60(11):971-7. doi: 10.1016/j.jacc.2012.05.029. Epub 2012 Aug 22.
6
Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association.用于预防非瓣膜性心房颤动患者卒中的口服抗血栓药物:美国心脏协会/美国卒中协会给医疗保健专业人员的科学建议
Stroke. 2012 Dec;43(12):3442-53. doi: 10.1161/STR.0b013e318266722a. Epub 2012 Aug 2.
7
What is the optimal anticoagulation in patients with a left ventricular assist device?对于使用左心室辅助装置的患者,最佳的抗凝治疗方案是什么?
Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):733-40. doi: 10.1093/icvts/ivs297. Epub 2012 Jul 3.
8
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.接受华法林治疗的急性缺血性脑卒中患者接受静脉注射组织型纤溶酶原激活物治疗后的颅内出血风险。
JAMA. 2012 Jun 27;307(24):2600-8. doi: 10.1001/jama.2012.6756.
9
Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial.巴西一项多方面干预措施对急性冠状动脉综合征患者采用循证治疗的效果:BRIDGE-ACS 随机试验
JAMA. 2012 May 16;307(19):2041-9. doi: 10.1001/jama.2012.413.
10
Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.窦性心律心力衰竭的血栓栓塞和抗血栓治疗。ESC 心力衰竭协会和 ESC 血栓形成工作组的联合共识文件。
Eur J Heart Fail. 2012 Jul;14(7):681-95. doi: 10.1093/eurjhf/hfs073. Epub 2012 May 19.